Leaflet EMETOSTOP 30mg tablets

Indicated for: nausea, vomiting and motion sickness

Route of administration: oral

Substance: meclozine (antiemetic)

ATC: R06AE05 (Respiratory system | Antihistamines for systemic use | Piperazine derivatives)

Meclozine is a medication used to prevent and treat nausea, vomiting, and dizziness associated with motion sickness, vertigo, or other inner ear disorders such as Ménière's disease. It belongs to the class of H1 antihistamines and works by blocking histamine receptors in the brain, thereby reducing the sensation of nausea and dizziness.

Meclozine is available in tablet form and can be taken 1-2 hours before travel to prevent motion sickness. It is also sometimes used to treat nausea during pregnancy, but only under medical supervision.

Side effects may include drowsiness, dry mouth, fatigue, blurred vision, or, in rare cases, allergic reactions. Patients should avoid alcohol consumption or operating vehicles during treatment, as meclizine may impair alertness.

EMETOSTOP 30mg tablets SPECIFAR, meclozine

General data about EMETOSTOP 30mg

  • Substance: meclozine
  • Date of latest medicines list: 01-05-2024
  • Product code: W13788001
  • Concentration: 30mg
  • Pharmaceutical form: tablets
  • Quantity: 10
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: SPECIFAR S.A. - GRECIA
  • Holder: SPECIFAR S.A. - GRECIA
  • Number: 7611/2015/01
  • Shelf life: 3 years